Read the docs
TI-2024-12075 Aliases CVE-2024-13026GHSA-mvrq-wf2x-8c9p

Inadequate Encryption Strength Vulnerability in Roche Algo Edge

Priority LOW 28CWE-326Published · Updated

Key facts

Attack vector
Adjacent network
Privileges required
None
User interaction
None
Attack complexity
High
Attack requirements
Present
Impact type
Information disclosure
Confidentiality · integrity · availability
Low · High · High
Fix status
Fixed

Attack profile from CVSS 4.0 · CNA. Fix status from CNA. Impact type from CWE-326.

Summary

A vulnerability exists in Algo Edge up to 2.1.1 - a previously used (legacy) component of navify® Algorithm Suite. The vulnerability impacts the authentication mechanism of this component and could allow an attacker with adjacent access to the laboratory network and the Algo Edge system to craft valid authentication tokens and access the component. Other components of navify® Algorithm Suite are not affected.

Why it matters now

Exploitation None reported CISA SSVC · not in CISA KEV
EPSS 0.00132 2nd percentileScored 2026-11-07
Fix Fixed Algorithm Suite (Roche Diagnostics): 2.1.2

SSVC decision points

CISA ADP · SSVC 2.0.3

Exploitation
None
Automatable
No
Technical impact
Total

The decision (Track, Attend, Act) also depends on your mission and well-being impact; see CISA's SSVC guide.

Affected products

VendorProductAffected versionsFixed inStatusSource
Roche DiagnosticsAlgorithm Suitebefore 2.1.22.1.2Patch availableCNA
  • Algorithm Suite VendorRoche Diagnostics Affected before 2.1.2 Fixed in 2.1.2 Patch available CNA

Remediation

  • Fix · CNA Algorithm Suite (Roche Diagnostics) Fixed in 2.1.2

Timeline

  1. 2026-10-02 Threatist record created from CVE-2024-13026
  2. 2026-10-03 Alias added: GHSA-mvrq-wf2x-8c9p

References

  • TI-2026-08618 Vulnerability in navify® Digital Pathology CVSS 4.0HIGH 8.8
  • TI-2025-07005 navify Monitoring API input validation CVSS 4.0HIGH 7.1

Sources